Healthcare provider profile · identity verified

Jonathan H Maks, MD

Internal Medicine · WILMETTE, IL · NPI 1720033160

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	455	111
Amlodipine Besylate	Amlodipine Besylate	371	81
Levothyroxine Sodium	Levothyroxine Sodium	247	61
Valsartan	Valsartan	233	56
Pantoprazole Sodium	Pantoprazole Sodium	213	60
Rosuvastatin Calcium	Rosuvastatin Calcium	177	66
Sertraline Hcl	Sertraline Hcl	177	47
Metoprolol Succinate	Metoprolol Succinate	157	47
Furosemide	Furosemide	153	30
Memantine Hcl	Memantine Hcl	151	15
Carvedilol	Carvedilol	123	26
Eliquis	Apixaban	116	23
Meloxicam	Meloxicam	115	38
Tamsulosin Hcl	Tamsulosin Hcl	111	28
Ezetimibe	Ezetimibe	110	33
Metformin Hcl Er	Metformin Hcl	105	37
Famotidine	Famotidine	98	39
Losartan Potassium	Losartan Potassium	98	26
Trazodone Hcl	Trazodone Hcl	96	17
Jardiance	Empagliflozin	95	27
Donepezil Hcl	Donepezil Hcl	94	15
Lisinopril	Lisinopril	94	30
Montelukast Sodium	Montelukast Sodium	93	20
Pravastatin Sodium	Pravastatin Sodium	92	24
Allopurinol	Allopurinol	87	19
Gabapentin	Gabapentin	87	21
Clonazepam	Clonazepam	85	16
Spironolactone	Spironolactone	85	13
Albuterol Sulfate Hfa	Albuterol Sulfate	82	49
Simvastatin	Simvastatin	81	24
Alprazolam	Alprazolam	80	22
Celecoxib	Celecoxib	79	14
Clopidogrel	Clopidogrel Bisulfate	79	13
Bupropion Hcl Sr	Bupropion Hcl	76	25
Omeprazole	Omeprazole	73	24
Duloxetine Hcl	Duloxetine Hcl	72	18
Escitalopram Oxalate	Escitalopram Oxalate	65	20
Methylprednisolone	Methylprednisolone	65	46
Azithromycin	Azithromycin	63	51
Metformin Hcl	Metformin Hcl	63	19
Tramadol Hcl	Tramadol Hcl	62	13
Finasteride	Finasteride	57	13
Hydrochlorothiazide	Hydrochlorothiazide	57	20
Myrbetriq	Mirabegron	56	suppressed
Mirtazapine	Mirtazapine	52	21
Ramipril	Ramipril	52	14
Potassium Chloride	Potassium Chloride	51	12
Lorazepam	Lorazepam	48	13
Venlafaxine Hcl Er	Venlafaxine Hcl	48	11
Vilazodone Hcl	Vilazodone Hcl	48	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	27
Propranolol Hcl	Propranolol Hcl	47	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	44	14
Synthroid	Levothyroxine Sodium	42	12
Mounjaro	Tirzepatide	39	suppressed
Aripiprazole	Aripiprazole	37	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	35	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Irbesartan	Irbesartan	34	12
Valacyclovir	Valacyclovir Hcl	34	16
Amiodarone Hcl	Amiodarone Hcl	33	suppressed
Azelastine Hcl	Azelastine Hcl	33	18
Alfuzosin Hcl Er	Alfuzosin Hcl	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Ozempic	Semaglutide	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	19
Metoprolol Tartrate	Metoprolol Tartrate	29	suppressed
Solifenacin Succinate	Solifenacin Succinate	29	12
Cefpodoxime Proxetil	Cefpodoxime Proxetil	26	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Galantamine Er	Galantamine Hbr	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Bupropion Hcl	Bupropion Hcl	24	suppressed
Penicillin V Potassium	Penicillin V Potassium	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Prednisone	Prednisone	22	12
Cephalexin	Cephalexin	21	13
Doxycycline Monohydrate	Doxycycline Monohydrate	21	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	14
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Levofloxacin	Levofloxacin	19	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Mupirocin	Mupirocin	19	15
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Digoxin	Digoxin	18	suppressed
Torsemide	Torsemide	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Nystatin	Nystatin	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Multaq	Dronedarone Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Baclofen	Baclofen	15	suppressed
Diclofenac Potassium	Diclofenac Potassium	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Lagevrio (Eua)	Molnupiravir	14	14
Midodrine Hcl	Midodrine Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Rivastigmine	Rivastigmine	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Felodipine Er	Felodipine	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Permethrin	Permethrin	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Vasotec	Enalapril Maleate	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Colchicine	Colchicine	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error